Integrated Filing — IndAS

General information about company
Scrip Code	540900
NSE Symbol	NEWGEN
MSEI Symbol	NOTLISTED
ISIN	INE619B01017
Name of company	NEWGEN SOFTWARE TECHNOLOGIES LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	02-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	24-Apr-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Geographical
Description of single segment
Start date and time of board meeting	02-May-2025   11:19:00
End date and time of board meeting	02-May-2025   12:10:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2025-03-20
Indicate Company website link for updated RPT policy of the Company	https://landing.newgensoft.com/hubfs/_2020%20Website%20files/IR/Policy-on-Related-Party-Transaction-2.pdf?_gl=1*13dxes7*_gcl_au*MTgzNDE4ODc1Mi4xNzM5MzQ0NDM2
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
Not Applicable

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	3939689000	13543539000
	Other income	132137000	596766000
	Total income	4071826000	14140305000
2	Expenses
(a)	Cost of materials consumed	0	0
(b)	Purchases of stock-in-trade	0	0
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	0	0
(d)	Employee benefit expense	1585810000	6165447000
(e)	Finance costs	13564000	45280000
(f)	Depreciation, depletion and amortisation expense	80425000	306726000
(f)	Other Expenses
1	Other Expenses	1069268000	3892571000
	Total other expenses	1069268000	3892571000
	Total expenses	2749067000	10410024000
3	Total profit before exceptional items and tax	1322759000	3730281000
4	Exceptional items	0	0
5	Total profit before tax	1322759000	3730281000
6	Tax expense
7	Current tax	306327000	906227000
8	Deferred tax	3247000	-108675000
9	Total tax expenses	309574000	797552000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	1013185000	2932729000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	1013185000	2932729000
17	Other comprehensive income net of taxes	9539000	-18734000
18	Total Comprehensive Income for the period	1022724000	2913995000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	1402130000	1402130000
	Face value of equity share capital	10	10
27	Details of debt securities
22	Reserves excluding revaluation reserve		12728935000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	7.23	20.96
	Diluted earnings (loss) per share from continuing operations	7.09	20.37
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	7.23	20.96
	Diluted earnings (loss) per share from continuing and discontinued operations	7.09	20.37
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results		ttttt nNotes:tttttt n1. The above financial results for the quarter and year ended 31 March 2025 were reviewed by the Audit Committee in their meeting held on 1 May 2025 and approved by the Board of Directors in their meeting held on 2 May 2025. Standalone and Consolidated financial results of the Company for the quarter and year ended 31 March 2025 are prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013 and relevant rules thereunder. The company has complied with the guidelines issued by Securities & Exchange Board of India (SEBI) to the extent applicable.ttttt n2. The auditors have carried out audit of Standalone and Consolidated results of the Company for the year ended 31 March 2025. There are no qualifications in the Auditor's report on these financial results. The figures for the quarter ended 31 March 2025 and 31 March 2024 are the balancing figures between the audited figures for full financial year and the unaudited figures upto the nine months ended 31 December 2024 and 31 December 2023, respectively, which were subjected to limited review by the statutory auditors. ttttt n3 The Board of Directors in their meeting held on 2 May 2025 recommended a dividend of INR 5.00 per equity share for the financial year ended 31 March 2025. The payment is subject to approval of shareholders at the ensuing Annual General Meeting.ttttt n4 Pursuant to Newgen ESOP Scheme 2022 and Newgen RSU 2021 scheme, the Board of Directors on 20 January 2025, allotted 3,93,385 and 9,40,000 shares respectively to Newgen ESOP Trust and Newgen RSU Trust through primary issue. Further, during the quarter, the Nomination & Remuneration Committee has granted 73,050 options to its employees under Newgen ESOP Scheme 2022 on 20 January 2025.ttttt n5tPrevious periods/years figures have been regrouped/reclassified wherever necessary to correspond with the current period/year classification/disclosure, which are not considered material to these financial results.ttttt nFor and on behalf of the Board of Directors of nNewgen Software Technologies Limited n nDiwakar Nigam nChairman & Managing Director nDIN: 00263222 n nPlace: New Delhi nDate: 2 May 2025

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	1713691000
	Capital work-in-progress	0
	Investment property	0
	Goodwill	28331000
	Other intangible assets	791301000
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	304056000
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	909231000
	Total non-current financial assets	1213287000
	Deferred tax assets (net)	182977000
	Other non-current assets	4761000
	Total non-current assets	3934348000
2	Current assets
	Inventories	0
	Current financial asset
	Current investments	5083962000
	Trade receivables, current	3607743000
	Cash and cash equivalents	450464000
	Bank balance other than cash and cash equivalents	2013943000
	Loans, current	5311000
	Other current financial assets	185744000
	Total current financial assets	11347167000
	Current tax assets (net)	192251000
	Other current assets	2938351000
	Total current assets	14477769000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	18412117000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	1402130000
	Other equity	12728935000
	Total equity attributable to owners of parent	14131065000
	Non controlling interest
	Total equity	14131065000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	0
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	373851000
	Total non-current financial liabilities	373851000
	Provisions, non-current	514851000
	Deferred tax liabilities (net)	0
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	888702000
	Current liabilities
	Current financial liabilities
	Borrowings, current	0
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	27792000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	809096000
	Total Trade payable	836888000
	Other current financial liabilities	628827000
	Total current financial liabilities	1465715000
	Other current liabilities	1561976000
	Provisions, current	96271000
	Current tax liabilities (Net)	268388000
	Deferred government grants, Current	0
	Total current liabilities	3392350000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	4281052000
	Total equity and liabilites	18412117000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
1	India	1336367000	4586841000
2	EMEA	1263806000	4486587000
3	APAC	661234000	2062516000
4	USA	678282000	2407595000
	Total Segment Revenue	3939689000	13543539000
	Less: Inter segment revenue	0	0
	Revenue from operations	3939689000	13543539000
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
1	India	273507000	721662000
2	EMEA	479290000	1440324000
3	APAC	265667000	762437000
4	USA	277739000	608629000
	Total Profit before tax	1296203000	3533052000
	i. Finance cost	13564000	13564000
	ii. Other Unallocable Expenditure net off Unallocable income	-40120000	-40120000
	Profit before tax	1322759000	3730281000
3	(Segment Asset - Segment Liabilities)
	Segment Asset
1	India	2566553000	2566553000
2	EMEA	2690226000	2690226000
3	APAC	833863000	833863000
4	USA	817727000	817727000
	Total Segment Asset	6908369000	6908369000
	Un-allocable Assets	11503748000	11503748000
	Net Segment Asset	18412117000	18412117000
4	Segment Liabilities
	Segment Liabilities
1	India	1176804000	1176804000
2	EMEA	1175121000	1175121000
3	APAC	439650000	439650000
4	USA	361037000	361037000
	Total Segment Liabilities	3152612000	3152612000
	Un-allocable Liabilities	1128440000	1128440000
	Net Segment Liabilities	4281052000	4281052000
	Disclosure of notes on segments	Textual Information(2)

Text Block

Textual Information(2)

a) Unallocated assets, liabilities, revenue and expenses : nCertain assets, liabilities, revenue and expenses are not specifically allocable to individual segments as the underlying services are used interchangeably. The Company believes that it is not practicable to provide segment disclosures relating to such assets, liabilities, revenue and expenses and accordingly such assets, liabilities, revenue and expenses are separately disclosed as ‘unallocated’

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Re-measurement gains / (losses) on defined benefit plans	19349000	-10952000
	Total Amount of items that will not be reclassified to profit and loss	19349000	-10952000
2	Income tax relating to items that will not be reclassified to profit or loss	6761000	-3827000
3	Amount of items that will be reclassified to profit and loss
1	Debt instruments through other comprehensive income -nnet change in fair value	-3975000	-15135000
	Total Amount of items that will be reclassified to profit and loss	-3975000	-15135000
4	Income tax relating to items that will be reclassified to profit or loss	-926000	-3526000
5	Total Other comprehensive income	9539000	-18734000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			3730281000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			44226000
	Adjustments for decrease (increase) in inventories			0
	Adjustments for decrease (increase) in trade receivables, current			-745534000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			-1325514000
	Adjustments for decrease (increase) in other non-current assets			-2975000
	Adjustments for other financial assets, non-current			-37632000
	Adjustments for other financial assets, current			-37752000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			265003000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			111754000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			306726000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			5455000
	Adjustments for provisions, non-current			28833000
	Adjustments for other financial liabilities, current			57392000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			19533000
	Adjustments for dividend income			0
	Adjustments for interest income			238874000
	Adjustments for share-based payments			235707000
	Adjustments for fair value losses (gains)			-198329000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			-92719000
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			244442000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			-1360258000
	Net cash flows from (used in) operations			2370023000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			611955000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			1758068000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			2958156000
	Other cash payments to acquire equity or debt instruments of other entities			4117658000
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			2617000
	Purchase of property, plant and equipment			230819000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			287920000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-48272000
	Net cash flows from (used in) investing activities	-1148056000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			48523000
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			0
	Repayments of borrowings			21992000
	Payments of lease liabilities			122888000
	Dividends paid			560857000
	Interest paid			1432000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			-658646000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-48634000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			-48634000
	Cash and cash equivalents cash flow statement at beginning of period			499098000
	Cash and cash equivalents cash flow statement at end of period			450464000